Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles-Reference-Cited by-同舟云学术

Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles

Published:2006-09 Issue:2 Volume:353 Page:451-462
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Pinto Ligia A.,Viscidi Raphael,Harro Clayton D.,Kemp Troy J.,García-Piñeres Alfonso J.,Trivett Matthew,Demuth Franklin,Lowy Douglas R.,Schiller John T.,Berzofsky Jay A.,Hildesheim Allan

Publisher

Elsevier BV

Subject

Virology

Reference37 articles.

1. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group;Bosch;J. Natl. Cancer Inst.,1995

2. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection;Breitburd;J. Virol.,1995

3. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy;Chan;J. Virol.,1995

4. Antibody-mediated neutralization in vivo of infectious papillomaviruses;Christensen;J. Virol.,1990

5. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in Colombian women with invasive cervical cancer;Combita;Int. J. Cancer,2002

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of cervical intraepithelial neoplasia grade 3 or more diagnoses for human papillomavirus16/18-positive women by cytology and co-infection status;Infectious Agents and Cancer;2023-10-09

2. Development of modern immunization agent against bovine papillomavirus type 1 infection based on BPV1 L1 recombinant protein;Frontiers in Veterinary Science;2023-03-28

3. Papillomavirus-like Particles in Equine Medicine;Viruses;2023-01-25

4. Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patient;International Journal of STD & AIDS;2021-10-11

5. Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials;The Lancet Infectious Diseases;2021-10